/TKNO

TKNO Stock - Alpha Teknova, Inc.

Q: What is the analyst price target for TKNO?

Analyst price target information is not currently available for TKNO.

Q: What is TKNO's market cap?

Market capitalization information is not currently available for TKNO.

Healthcare|Drug Manufacturers - Specialty & Generic|NASDAQ

$4.65+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $5.12

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for TKNO

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.41

52W High$10.37

52W Low$3.94

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$37.74M	$36.68M	$41.42M	$36.89M	$31.30M
Gross Profit	$7.23M	$10.30M	$17.48M	$17.62M	$17.75M
Gross Margin	19.2%	28.1%	42.2%	47.8%	56.7%
Operating Income	$-26,146,000	$-35,563,000	$-49,659,000	$-12,008,000	$4.66M
Net Income	$-26,745,000	$-36,780,000	$-47,468,000	$-9,803,000	$3.57M
Net Margin	-70.9%	-100.3%	-114.6%	-26.6%	11.4%
EPS	$-0.57	$-1.16	$-1.69	$-0.35	$0.03

Company Overview

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

50%

Hold / Neutral

50%

Sell / Underperform

Analyst Consensus🟡 Mixed

1 Bullish1 Neutral/Bearish

Price Targets

$10

Average Target

↑ 115.1% Upside

Now

Low

$10

Average

$12

High

Based on 2 analysts

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
July 22nd 2025	Stephens	Resumed	Overweight	$8
February 10th 2025	Craig Hallum	Initiation	Buy	$12
March 12th 2024	BTIG Research	Downgrade	Neutral	-

Earnings History & Surprises

TKNO

Beat Rate

61%

Last 18 quarters

Avg Surprise

-33.3%

EPS vs Estimate

Beats / Misses

11/5

2 met exactly

Latest EPS

$-0.08

Q4 2025

EPS Surprise History

Q1 24

+4.3%

$-0.22vs$-0.23

Q2 24

+16.7%

$-0.20vs$-0.24

Q3 24

+18.8%

$-0.13vs$-0.16

Q4 24

-36.4%

$-0.15vs$-0.11

Q1 25

+8.3%

$-0.11vs$-0.12

Q2 25

+18.2%

$-0.09vs$-0.11

Q3 25

+30.3%

$-0.07vs$-0.10

Q4 25

+14.7%

$-0.08vs$-0.09

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2025	Nov 6, 2025	$-0.09	$-0.08	+14.7%	✓ BEAT
Q3 2025	Aug 7, 2025	$-0.10	$-0.07	+30.3%	✓ BEAT
Q2 2025	May 8, 2025	$-0.11	$-0.09	+18.2%	✓ BEAT
Q1 2025	Mar 4, 2025	$-0.12	$-0.11	+8.3%	✓ BEAT
Q4 2024	Nov 7, 2024	$-0.11	$-0.15	-36.4%	✗ MISS
Q3 2024	Aug 13, 2024	$-0.16	$-0.13	+18.8%	✓ BEAT
Q2 2024	May 13, 2024	$-0.24	$-0.20	+16.7%	✓ BEAT
Q1 2024	Mar 11, 2024	$-0.23	$-0.22	+4.3%	✓ BEAT
Q4 2023	Nov 9, 2023	$-0.28	$-0.34	-21.4%	✗ MISS
Q3 2023	Aug 10, 2023	$-0.26	$-0.25	+3.8%	✓ BEAT
Q2 2023	May 10, 2023	$-0.30	$-0.31	-3.3%	✗ MISS
Q1 2023	Mar 15, 2023	$0.34	$-0.47	-238.2%	✗ MISS
Q4 2022	Nov 9, 2022	$-0.29	$-0.21	+27.6%	✓ BEAT
Q3 2022	Aug 10, 2022	$-0.25	$-0.22	+12.0%	✓ BEAT
Q2 2022	May 11, 2022	$-0.20	$-0.20	0.0%	= MET
Q1 2022	Mar 15, 2022	$-0.17	$-0.13	+23.5%	✓ BEAT
Q4 2021	Nov 10, 2021	$-0.12	$-0.12	0.0%	= MET
Q3 2021	Aug 11, 2021	$-0.09	$-0.52	-477.8%	✗ MISS
Q2 2021	Jun 25, 2021	—	$0.03	—	—
Q1 2021	Mar 31, 2021	—	$-0.03	—	—

Frequently Asked Questions about TKNO

What is TKNO's current stock price?

Alpha Teknova, Inc. (TKNO) is currently trading at $4.65 per share. The stock has moved +0.00% today.

What is the analyst price target for TKNO?

No analyst price targets are currently available for this stock.

What sector is Alpha Teknova, Inc. in?

Alpha Teknova, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the NASDAQ exchange.

What is TKNO's market cap?

Alpha Teknova, Inc. has a market capitalization of $0.25 billion, making it a small-cap company.

Does TKNO pay dividends?

No, Alpha Teknova, Inc. does not currently pay a dividend to shareholders.